Feng Ji1, Yue-Liang Chen, En-Yun Jin, Wei-Lin Wang, Zi-Li Yang, You-Ming Li. 1. Department of Gastroenterology, First Affiliated Hospital of Medical College, Zhejiang University, Qingchun Road 79, Hangzhou 310003, Zhejiang Province, China. jifeng1126@sina.com.cn
Abstract
AIM: To investigate the relationship between matrix metalloproteinase-2 (MMP-2) mRNA expression and clinicopathologic and urokinase-type plasminogen activator (uPA) system parameter and prognosis in human gastric cancer. METHODS: Expression of MMP-2 mRNA, uPA, and uPA-R mRNA in tumor tissues and > or =5 cm adjacent normal tissues from 67 cases of gastric cancer was studied using RT-PCR and Northern blot respectively. Survival analyses were done using the Kaplan-Meier method. RESULTS: The expression rates of MMP-2 mRNA, uPA and uPA-R mRNA in tumor tissues (31%, 41%, and 51%, respectively) were significantly higher than those in > or =5 cm adjacent tissues (19%, 11%, and 9%; chi(2) = 4.59, 43.58, and 53.24 respectively, P<0.05, 0.0001, and 0.0001, respectively). Expression of MMP-2 mRNA was significantly correlated with lymph node metastasis (metastasis: 61.9%, no metastasis: 39.1%, chi(2) = 7.61, P<0.05), Lauren's classification of diffuse/mixed types: 54.2%, intestinal type: 26.3%, chi(2) = 4.25, P<0.05, expression of uPA and uPA-R mRNA (uPA+: 55.1%, uPA-: 22.2% and uPA-R+: 54.9%, uPA-R-: 18.8%, chi(2) = 5.72 and 6.40 respectively, P<0.05). Kaplan-Meier survival analysis of MMP-2 mRNA expression did not show significant difference in all 67 cases, but revealed an association of the expression of MMP-2 mRNA, uPA, and uPA-R mRNA with worse prognosis (P = 0.0083, 0.0160, and 0.0094, respectively). CONCLUSION: MMP-2 may play an important role in the development of invasion and metastasis of gastric cancer.
AIM: To investigate the relationship between matrix metalloproteinase-2 (MMP-2) mRNA expression and clinicopathologic and urokinase-type plasminogen activator (uPA) system parameter and prognosis in humangastric cancer. METHODS: Expression of MMP-2 mRNA, uPA, and uPA-R mRNA in tumor tissues and > or =5 cm adjacent normal tissues from 67 cases of gastric cancer was studied using RT-PCR and Northern blot respectively. Survival analyses were done using the Kaplan-Meier method. RESULTS: The expression rates of MMP-2 mRNA, uPA and uPA-R mRNA in tumor tissues (31%, 41%, and 51%, respectively) were significantly higher than those in > or =5 cm adjacent tissues (19%, 11%, and 9%; chi(2) = 4.59, 43.58, and 53.24 respectively, P<0.05, 0.0001, and 0.0001, respectively). Expression of MMP-2 mRNA was significantly correlated with lymph node metastasis (metastasis: 61.9%, no metastasis: 39.1%, chi(2) = 7.61, P<0.05), Lauren's classification of diffuse/mixed types: 54.2%, intestinal type: 26.3%, chi(2) = 4.25, P<0.05, expression of uPA and uPA-R mRNA (uPA+: 55.1%, uPA-: 22.2% and uPA-R+: 54.9%, uPA-R-: 18.8%, chi(2) = 5.72 and 6.40 respectively, P<0.05). Kaplan-Meier survival analysis of MMP-2 mRNA expression did not show significant difference in all 67 cases, but revealed an association of the expression of MMP-2 mRNA, uPA, and uPA-R mRNA with worse prognosis (P = 0.0083, 0.0160, and 0.0094, respectively). CONCLUSION:MMP-2 may play an important role in the development of invasion and metastasis of gastric cancer.
Authors: A Krüger; R Soeltl; V Lutz; O G Wilhelm; V Magdolen; E E Rojo; P A Hantzopoulos; H Graeff; B Gänsbacher; M Schmitt Journal: Cancer Gene Ther Date: 2000-02 Impact factor: 5.987
Authors: Y Herouy; J Aizpurua; C Stetter; S Dichmann; M Idzko; C Hofmann; G Gitsch; W Vanscheidt; E Schöpf; J Norgauer Journal: J Cutan Pathol Date: 2001-07 Impact factor: 1.587
Authors: Duc M Le; Arnaud Besson; Darrin K Fogg; Kyu-Sil Choi; David M Waisman; Cynthia G Goodyer; Barry Rewcastle; V Wee Yong Journal: J Neurosci Date: 2003-05-15 Impact factor: 6.167
Authors: W F Grigioni; A D'Errico; C Fortunato; M Fiorentino; A M Mancini; W G Stetler-Stevenson; M E Sobel; L A Liotta; M Onisto; S Garbisa Journal: Mod Pathol Date: 1994-02 Impact factor: 7.842
Authors: Ulrich J Knappe; Christian Hagel; Björn W Lisboa; Waldemar Wilczak; Dieter K Lüdecke; Wolfgang Saeger Journal: Acta Neuropathol Date: 2003-08-02 Impact factor: 17.088
Authors: C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget Journal: Br J Cancer Date: 1996-08 Impact factor: 7.640
Authors: Eduardo Rodrigues Fregnani; Lays M Sobral; Fabio Abreu Alves; Fernando Augusto Soares; Luis Paulo Kowalski; Ricardo D Coletta Journal: Pathol Oncol Res Date: 2008-12-19 Impact factor: 3.201
Authors: F J G M Kubben; C F M Sier; W van Duijn; G Griffioen; R Hanemaaijer; C J H van de Velde; J H J M van Krieken; C B H W Lamers; H W Verspaget Journal: Br J Cancer Date: 2006-04-10 Impact factor: 7.640